TWD
TNXP icon

True Wealth Design’s Tonix Pharmaceuticals TNXP Stock Holding History

True Wealth Design’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.49K Buy
352
+306
+665% +$3.95K ﹤0.01% 1375
2026
Q1 		$633 Buy
+46
New +$708 ﹤0.01% 1961

Other funds holding TNXP

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CNBT
Cornerstone National Bank & Trust Palatine, Illinois $296M AUM 12.13% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
WETS
Wealth Enhancement Trust Services Sioux Falls, South Dakota $900M AUM
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

True Wealth Design's TNXP Position: Q2 2026 in Review

True Wealth Design increased its Tonix Pharmaceuticals (TNXP) stake by 665% in Q2 2026, buying an estimated $3.95K and bringing the position to 352 shares worth $4.49K. The position accounts for ﹤0.01% of the portfolio, ranked #1375.

True Wealth Design first reported a position in TNXP in Q1 2026 and has held it in 2 quarters since. 13 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • True Wealth Design held 352 shares of Tonix Pharmaceuticals worth $4.49K as of Q2 2026.
  • True Wealth Design bought 306 Tonix Pharmaceuticals shares in Q2 2026, an estimated $3.95K.
  • Tonix Pharmaceuticals made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1375 holding.
  • True Wealth Design first reported a position in Tonix Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 13 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.